CannaPharmaRX, Inc.

CPMD

US13765D1090

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 18:46:00 17/04/2024 BST			5-day change	1st Jan Change
0.01 ^USD	-31.03%		-.--%	+488.24%

03-14	CannaPharmaRX, Inc. Receives First Purchase Order and Begins Shipment of Product	CI
03-05	CannaPharmaRX, Inc. Executes Multi-Year Supply Agreement with Ican to Create Distribution Network in the Latin Americas	CI

CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022

September 01, 2023 at 06:09 pm

CannaPharmaRX, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 8.53 million compared to USD 8.83 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.12 a year ago.

Latest news about CannaPharmaRX, Inc.

CannaPharmaRX, Inc. Receives First Purchase Order and Begins Shipment of Product	03-14	CI
CannaPharmaRX, Inc. Executes Multi-Year Supply Agreement with Ican to Create Distribution Network in the Latin Americas	03-05	CI
CannaPharmaRx, Inc Enters into Strategic Supply Agreement with Cantek Holdings	02-16	CI
CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-17	CI
CannaPharmaRX, Inc. Announces Executive Changes	13/10/23	CI
CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13/10/23	CI
CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	22/09/23	CI
CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/09/23	CI
CannaPharmaRx Expands Board of Directors	25/08/23	CI
CannaPharmaRX, Inc. Announces CEO Changes	23/06/23	CI
CannaPharmaRX, Inc. Signs Supply Agreement with Y.S.A Holdings for Up to $15 Million Annually of Commercial Cannabis	30/03/23	CI
CannaPharmaRX, Inc. completed the acquisition of LTB Management LLC.	20/03/23	CI
CannaPharmaRX, Inc. agreed to acquire LTB Management LLC.	20/02/23	CI
CannaPharmaRx Receives Canada Revenue Agency License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected	11/01/23	CI
CannaPharmaRx, Inc Receives Cultivation License from Health Canada and Projects 2023 Revenue over $30 Million	21/12/22	CI
CannaPharmaRX, Inc. Provides Revenue Guidance for the Full Year 2023	21/12/22	CI
CannaPharmaRx, Inc. Receives Cultivation License from Health Canada	21/12/22	CI
CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/11/22	CI
CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22/08/22	CI
CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23/05/22	CI
CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/04/22	CI
CannaPharmaRX, Inc. Auditor Raises 'Going Concern' Doubt	14/04/22	CI
CannaPharmaRx, Inc Signs Letter of Intent to Purchase an Operating Cannabis Facility Located in Braman, Oklahoma	16/02/22	CI
CannaPharmaRX, Inc. signed a letter of intent to acquire Operating Cannabis Facility Located in Braman, Oklahoma.	09/02/22	CI
CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21	CI

Chart CannaPharmaRX, Inc.

Duration

Period

More charts

Company Profile

CannaPharmaRx, Inc. is focused on the acquisition and development of state-of-the-art cannabis growing facilities in Canada. The Company is engaged in producing customizable medical cannabis and craft products. Its business strategy is to produce a high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. The Company is focused on operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis. The Company also offers a range of services to assist with cannabis inventory management.

Sector

Pharmaceuticals

Calendar

13/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CANNAPHARMARX, INC.	+488.24%	6.54M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals